These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 23968726

  • 21. Molecular Pathological Differences in Global Gene Expression between Two Sustained Proliferative Lesions, Nodular Regenerative Hepatocellular Hyperplasia and Hepatocellular Adenoma, in Mice.
    Takasu S, Yokoo Y, Ishii Y, Kijima A, Ogawa K, Umemura T.
    Toxicol Pathol; 2019 Jan; 47(1):44-52. PubMed ID: 30572783
    [Abstract] [Full Text] [Related]

  • 22. Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis.
    Phillips JM, Yamamoto Y, Negishi M, Maronpot RR, Goodman JI.
    Toxicol Sci; 2007 Mar; 96(1):72-82. PubMed ID: 17172636
    [Abstract] [Full Text] [Related]

  • 23. Piperonyl butoxide induces hepatocellular carcinoma in male CD-1 mice.
    Takahashi O, Oishi S, Fujitani T, Tanaka T, Yoneyama M.
    Arch Toxicol; 1994 Mar; 68(7):467-9. PubMed ID: 7979964
    [Abstract] [Full Text] [Related]

  • 24. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice.
    Moto M, Okamura M, Muguruma M, Ito T, Jin M, Kashida Y, Mitsumori K.
    Toxicol Pathol; 2006 Mar; 34(6):744-51. PubMed ID: 17162532
    [Abstract] [Full Text] [Related]

  • 25. Progressive alterations in global and GC-rich DNA methylation during tumorigenesis.
    Watson RE, Curtin GM, Doolittle DJ, Goodman JI.
    Toxicol Sci; 2003 Oct; 75(2):289-99. PubMed ID: 12883089
    [Abstract] [Full Text] [Related]

  • 26. Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure.
    Ozden S, Turgut Kara N, Sezerman OU, Durasi İM, Chen T, Demirel G, Alpertunga B, Chipman JK, Mally A.
    Toxicol Appl Pharmacol; 2015 Dec 01; 289(2):203-12. PubMed ID: 26431795
    [Abstract] [Full Text] [Related]

  • 27. Oncogenicity studies of piperonyl butoxide in rats and mice.
    Butler WH, Gabriel KL, Osimitz TG, Preiss FJ.
    Hum Exp Toxicol; 1998 Jun 01; 17(6):323-30. PubMed ID: 9688356
    [Abstract] [Full Text] [Related]

  • 28. Identification of biomarkers of chemically induced hepatocarcinogenesis in rasH2 mice by toxicogenomic analysis.
    Park HJ, Oh JH, Park SM, Cho JW, Yum YN, Park SN, Yoon DY, Yoon S.
    Arch Toxicol; 2011 Dec 01; 85(12):1627-40. PubMed ID: 21607683
    [Abstract] [Full Text] [Related]

  • 29. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y, Segawa R, Kimura M, Wang L, Ishii Y, Yamamoto R, Morita R, Mitsumori K, Shibutani M.
    Chem Biol Interact; 2013 Sep 25; 205(2):108-18. PubMed ID: 23830814
    [Abstract] [Full Text] [Related]

  • 30. Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats.
    Phillips JC, Price RJ, Cunninghame ME, Osimitz TG, Cockburn A, Gabriel KL, Preiss FJ, Butler WH, Lake BG.
    Fundam Appl Toxicol; 1997 Jul 25; 38(1):64-74. PubMed ID: 9268606
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
    Loeppen S, Schneider D, Gaunitz F, Gebhardt R, Kurek R, Buchmann A, Schwarz M.
    Cancer Res; 2002 Oct 15; 62(20):5685-8. PubMed ID: 12384525
    [Abstract] [Full Text] [Related]

  • 32. Altered methylation in gene-specific and GC-rich regions of DNA is progressive and nonrandom during promotion of skin tumorigenesis.
    Bachman AN, Curtin GM, Doolittle DJ, Goodman JI.
    Toxicol Sci; 2006 Jun 15; 91(2):406-18. PubMed ID: 16569730
    [Abstract] [Full Text] [Related]

  • 33. Lack of nrf2 results in progression of proliferative lesions to neoplasms induced by long-term exposure to non-genotoxic hepatocarcinogens involving oxidative stress.
    Tasaki M, Kuroiwa Y, Inoue T, Hibi D, Matsushita K, Kijima A, Maruyama S, Nishikawa A, Umemura T.
    Exp Toxicol Pathol; 2014 Jan 15; 66(1):19-26. PubMed ID: 23988840
    [Abstract] [Full Text] [Related]

  • 34. Oxidative DNA damage and reporter gene mutation in the livers of gpt delta rats given non-genotoxic hepatocarcinogens with cytochrome P450-inducible potency.
    Tasaki M, Umemura T, Suzuki Y, Hibi D, Inoue T, Okamura T, Ishii Y, Maruyama S, Nohmi T, Nishikawa A.
    Cancer Sci; 2010 Dec 15; 101(12):2525-30. PubMed ID: 20735435
    [Abstract] [Full Text] [Related]

  • 35. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
    Manoharan H, Babcock K, Pitot HC.
    Mol Carcinog; 2004 Sep 15; 41(1):1-16. PubMed ID: 15352122
    [Abstract] [Full Text] [Related]

  • 36. Expression patterns of cell cycle proteins in the livers of rats treated with hepatocarcinogens for 28 days.
    Yafune A, Taniai E, Morita R, Nakane F, Suzuki K, Mitsumori K, Shibutani M.
    Arch Toxicol; 2013 Jun 15; 87(6):1141-53. PubMed ID: 23411599
    [Abstract] [Full Text] [Related]

  • 37. Molecular pathological analysis on the mechanism of liver carcinogenesis in dicyclanil-treated mice.
    Moto M, Okamura M, Muto T, Kashida Y, Machida N, Mistumori K.
    Toxicology; 2005 Feb 28; 207(3):419-36. PubMed ID: 15664270
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.
    Clin Cancer Res; 2002 Apr 28; 8(4):1087-92. PubMed ID: 11948118
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.